...
首页> 外文期刊>Journal of Neuroimmunology: Official Bulletin of the Research Committee on Neuroimmunology of the World Federation of Neurology >Isolated CNS involvement in eosinophilic granulomatosis with polyangiitis treated with mepolizumab: A case report
【24h】

Isolated CNS involvement in eosinophilic granulomatosis with polyangiitis treated with mepolizumab: A case report

机译:孤立的CNS参与含有Mepolizumab的多苯炎的嗜酸性粒细胞芽孢杆菌:案例报告

获取原文
获取原文并翻译 | 示例
           

摘要

Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic vasculitis disease involving small-sized vessels. The literature has reported involvement of the central nervous system (CNS) in 5% cases, and isolated CNS involvement is extremely rare. Due to its rarity and scarcity of clinical data, standardized treatment of isolated CNS involvement in EGPA is unclear. Mepolizumab, an anti-interleukin-5 monoclonal antibody, was previously introduced to treat EGPA with longer remission period, more patients showing remission, and reduction in prednisolone dose of those who already taking prednisolone compared to placebo. We describe a case of isolated CNS involvement in EGPA, confirmed by brain biopsy and treated with mepolizumab, which was refractory to conventional immunotherapy.
机译:嗜酸性肉芽肿伴多血管炎(EGPA)是一种涉及小血管的系统性血管炎疾病。文献报道有5%的病例累及中枢神经系统(CNS),孤立的CNS累及极为罕见。由于临床数据稀少,EGPA孤立性中枢神经系统受累的标准化治疗尚不清楚。美波利珠单抗是一种抗白细胞介素-5的单克隆抗体,以前被用于治疗EGPA,其缓解期更长,出现缓解的患者更多,与安慰剂相比,已经服用泼尼松龙的患者的泼尼松龙剂量减少。我们描述了一例EGPA中孤立性中枢神经系统受累的病例,经脑活检证实,并用常规免疫治疗无效的美波利珠单抗治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号